August 2018

Volume 14 Number 5

EDITORIAL

Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: too early to draw conclusions

Lønborg J, Engstrøm T, De Backer O, Søndergaard L

August 3, 2018 | 10.4244/EIJV14I5A85

Sizing for self-expanding transcatheter aortic valve implantation

Jilaihawi H, Zhao Z-G, Williams M

August 3, 2018 | 10.4244/EIJV14I5A86

Urgent balloon aortic valvuloplasty in cardiogenic shock patients: still state of the art in the TAVI era?

Frerker C

August 3, 2018 | 10.4244/EIJV14I5A87

Reducing radiation exposure during PCI of chronic total occlusions – better is not good enough

Werner G

August 3, 2018 | 10.4244/EIJV14I5A88

PERSPECTIVES

Microvascular disease, what little we know

Appelman Y

August 3, 2018 | 10.4244/EIJV14I5A89

INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

CLINICAL RESEARCH

Transcatheter aortic valve implantation versus conservative treatment in chronic kidney disease patients

Steinmetz T, Witberg G, Chagnac A, Green H, Sagie A, Rozen-Zvi B, Kornowski R

August 3, 2018 | 10.4244/EIJ-D-18-00058

CLINICAL RESEARCH

Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve

Kim U, Blanke P, Windecker S, Kasel A, Schäfer U, Walters D, Linke A, Le Breton H, Schymik G, Spence M, Søndergaard L, Abdel-Wahab M, Worthley S, Tchétché D, Reichenspurner H, Ohana M, Sellers S, Leipsic J

August 3, 2018 | 10.4244/EIJ-D-17-01040

CLINICAL RESEARCH

Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters

Debry N, Kone P, Vincent F, Lemesle G, Delhaye C, Schurtz G, Spillemaeker H, Porouchani S, Coisne A, Auffray J-L, Sudre A, Lamblin N, Bonello L, Van Belle E

August 3, 2018 | 10.4244/EIJ-D-18-00029

INTERVENTIONAL FLASHLIGHT

Ad hoc percutaneous paravalvular leak closure after transcatheter aortic valve replacement facilitated by integrated multimodality imaging

Xiong T, Martucci G, Alosaimi H, Piazza N

August 3, 2018 | 10.4244/EIJ-D-17-01106

INTERVENTIONAL FLASHLIGHT

Successful transcatheter aortic valve replacement using a self-expanding bioprosthesis in a patient with a unicuspid aortic valve associated with severe regurgitation and cardiogenic shock

Huchet F, Roussel J, Letocart V, Manigold T

August 3, 2018 | 10.4244/EIJ-D-17-01108

CORONARY INTERVENTIONS

CLINICAL RESEARCH

Intracoronary electrocardiogram to guide percutaneous interventions in coronary bifurcations – a proof of concept: the FIESTA (Ffr vs. IcEcgSTA) study

Vassilev D, Dosev L, Collet C, Karamfiloff K, Stoikova J, Pancheva R, Shumkova M, Zlatancheva G, Naunov V, Rigatelli G, Kassab G, Gil R, Serruys P

August 3, 2018 | 10.4244/EIJ-D-17-00189

CLINICAL RESEARCH

Safety and feasibility of a low frame rate protocol for percutaneous coronary intervention to chronic total occlusions: preliminary experience

Ge L, Zhong X, Ma J, Fan B, Lu H, Qian J, Ge J

August 3, 2018 | 10.4244/EIJ-D-17-00515

CLINICAL RESEARCH

One-year clinical outcomes after unrestricted implantation of the Absorb bioresorbable scaffold (RAI registry)

Ielasi A, Cortese B, Moscarella E, Loi B, Tarantini G, Varricchio A, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Pietro Mazzarotto P, Tespili M, Orrego P, Corrado D, Steffenino G

August 3, 2018 | 10.4244/EIJ-D-17-00443

CLINICAL RESEARCH

Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial

Xu B, Yang Y, Han Y, Huo Y, Wang L, Qi X, Li J, Chen Y, Kuo H-C, Ying S, Cheong W-F, Zhang Y, Su X, Popma J, Gao R, Stone G

August 3, 2018 | 10.4244/EIJ-D-17-00796

CLINICAL RESEARCH

Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry

Buccheri S, Sarno G, Lagerqvist B, Olivecrona G, Hambraeus K, Witt N, Lindholm D, Erlinge D, Angeras O, James S

August 3, 2018 | 10.4244/EIJ-D-18-00392

CLINICAL RESEARCH

Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy

Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernandez-Antolin R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber J, von Birgelen C, Sabate M, Onuma Y, Serruys P

August 3, 2018 | 10.4244/EIJ-D-17-00461

CLINICAL RESEARCH

Impact of bleeding assessment and adjudication methodology on event rates and clinical trial outcomes: insights from the HORIZONS-AMI trial

Kosmidou I, Mintz G, Jatene T, Embacher M, Redfors B, Wong SC, Dressler O, Mehran R, Ben-Yehuda O, Jenkins PL, Stone G

August 3, 2018 | 10.4244/EIJ-D-18-00131

INTERVENTIONAL FLASHLIGHT

Recovery of absolute coronary flow and resistance one week after percutaneous coronary intervention of a chronic totally occluded coronary artery using the novel RayFlow© infusion catheter

Keulards D, Zimmermann F, Pijls N, Teeuwen K

August 3, 2018 | 10.4244/EIJ-D-17-00824

INTERVENTIONS FOR HYPERTENSION AND STROKE

CLINICAL RESEARCH

Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry

Landmesser U, Tondo C, Camm J, Diener H-C, Paul V, Schmidt B, Settergren M, Teiger E, Nielsen-Kudsk J, Hildick-Smith D

August 3, 2018 | 10.4244/EIJ-D-18-00344

WILL THIS TRIAL CHANGE MY PRACTICE? | Proceedings of

Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications

Ewen S, Lauder L, Azizi M, Kandzari D, Pathak A, Sharif F, Wijns W, Mahfoud F, Lüscher T

August 3, 2018 | 10.4244/EIJY18M07_1

Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medications

Lauder L, Ewen S, Azizi M, Mauri L, Lurz P, Lobo M, Sharif F, Wijns W, Tsioufis C, Mahfoud F

Volume 14 Number 5

EDITORIAL

PERSPECTIVES

INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

CORONARY INTERVENTIONS

INTERVENTIONS FOR HYPERTENSION AND STROKE

WILL THIS TRIAL CHANGE MY PRACTICE? | Proceedings of

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke